Importance of cerebrospinal fluid storage conditions for the Alzheimer's disease diagnostics on an automated platform

Objectives: Alzheimer's disease (AD) is considered the most common cause of dementia in older people. Cerebrospinal fluid (CSF) Aβ1-42, Aβ1-40, total Tau (t-Tau), and phospho Tau (p-Tau) are important biomarkers for the diagnosis, however, they are highly dependent on the pre-analytical conditi...

ver descrição completa

Detalhes bibliográficos
Autores: Ferrer Pérez, Rosa|||0009-0004-9477-699X, Zhu, Nuole|||0000-0002-0015-9455, Arranz Martínez, Javier|||0000-0003-0891-1215, Porcel, Inmaculada, El Bounasri El Bennadi, Shaimaa|||0000-0003-1580-9649, Sánchez, Oriol|||0000-0001-9405-1236, Torres Alcalá, Soraya|||0000-0002-7054-2046, Julve i Gil, Josep|||0000-0002-6531-2246, Lleó, Alberto|||0000-0002-2568-5478, Blanco Vaca, Francisco|||0000-0001-7380-5385, Alcolea, Daniel|||0000-0002-3819-3245, Tondo Colomer, Mireia|||0000-0002-0301-9984
Formato: artículo
Fecha de publicación:2022
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:271555
Acesso em linha:https://ddd.uab.cat/record/271555
https://dx.doi.org/urn:doi:10.1515/cclm-2022-0134
Access Level:acceso abierto
Palavra-chave:Alzheimer's disease
Amyloid
Automated platforms
Biomarkers
Cerebrospinal fluid
Tau
Descrição
Resumo:Objectives: Alzheimer's disease (AD) is considered the most common cause of dementia in older people. Cerebrospinal fluid (CSF) Aβ1-42, Aβ1-40, total Tau (t-Tau), and phospho Tau (p-Tau) are important biomarkers for the diagnosis, however, they are highly dependent on the pre-analytical conditions. Our aim was to investigate the potential influence of different storage conditions on the simultaneous quantification of these biomarkers in a fully-automated platform to accommodate easier pre-analytical conditions for laboratories. Methods: CSF samples were obtained from 11 consecutive patients. Aβ1-42, Aβ1-40, p-Tau, and t-Tau were quantified using the LUMIPULSE G600II automated platform. Results: Temperature and storage days significantly influenced Aβ1-42 and Aβ1-40 with concentrations decreasing with days spent at 4 °C. The use of the Aβ1-42/Aβ1-40 ratio could partly compensate it. P-Tau and t-Tau were not affected by any of the tested storage conditions. For conditions involving storage at 4 °C, a correctionfactor of 1.081 can be applied. Diagnostic agreement was almost perfect in all conditions. Conclusions: Cutoffs calculated in samples stored at-80 °C can be safely used in samples stored at-20 °C for 15-16 days or up to two days at RT and subsequent freezing at-80 °C. For samples stored at 4 °C, cutoffs would require applying a correction factor, allowing to work with the certainty of reaching the same clinical diagnosis.